In 2013, the global pharmaceutical packaging market is expected to reach 62.3 billion U.S. dollars. The United States continues to lead with 28% of its share; China's growth is strong and its annual growth rate is expected to be 11.5%
At present, the pharmaceutical industry has fully realized the importance of good packaging design, because it faces constant pressure in helping patients comply with drug regulations, meet regulatory requirements, increase the longevity and attractiveness of brands. At the same time, pharmaceutical companies must innovate and increase efficiency in response to the growing threat of counterfeit drugs. In addition, the pressure faced by the pharmaceutical industry is that we must pay attention to green production methods and shoulder greater responsibility for environmental protection. In this highly regulated industry, where is the development direction of the pharmaceutical packaging industry? What are the opportunities? What obstacles need to be overcome to succeed in this highly competitive market?
In 2013, the size of the global pharmaceutical packaging market is expected to reach 62.3 billion U.S. dollars, and the United States will continue to dominate this market, accounting for 28% of global pharmaceutical packaging sales. Globally, the growth rate in the Asia-Pacific region will be the strongest, and China will be the largest promoter of growth in the pharmaceutical packaging industry in the region, with an annual growth rate of 11.5%.
Developed countries continue to lead
Although the pharmaceutical packaging market in developing countries is expected to expand significantly in the next five years, their development will not harm the interests of developed countries. Therefore, Western Europe, Japan and the United States will continue to occupy the vast majority of the market share in the global pharmaceutical packaging market. In these three regions, the pharmaceutical packaging market will focus on value-added packaging systems and new drug delivery vehicles. Martineau predicts that the constant development of biotech drugs will boost the demand for parenteral packaging, especially small vials and pre-filled syringes.
The government's increasing standards for pharmaceutical packaging (ie, requiring unit doses, high barriers, and anti-counterfeit packaging) will affect the Western European market, while Japan will continue to be a pharmaceutical container, a capper, and due to the breadth of its patented pharmaceutical and generic pharmaceutical manufacturers. A large and diverse consumer country with related accessories.
Developing countries move forward
Bill Martineau, an analyst at Freedonia Group, a publisher of the report "Global Pharmaceutical Packaging," said that in the coming years, driven by several factors, the pharmaceutical packaging industry in developing countries will show the highest growth rate. One of the most important factors is that people use low-cost generics more and more easily, and the use of drug therapy to make up for the lack of health care implementation system will also promote the growth of pharmaceutical packaging in these areas.
The development of the global pharmaceutical packaging market will be maintained with the gradual use of high-value packaging systems. The role of these higher-value packaging systems is reflected in: improving the compliance of patients with drugs; reducing the risk of drug counterfeiting and transfer; The dangers of drug distribution errors; providing support for health care organizations to raise standards for infection prevention; and providing tools that differentiate them from other generic drugs.
Martineau explained that the development of China's pharmaceutical packaging market will be driven by the gradual adoption of GMP standards that are aligned with developed countries in the domestic pharmaceutical industry, and this will certainly promote the overall upgrade of China's pharmaceutical packaging system. As for the rest of the world, India is expected to show strong growth, because India's patented pharmaceutical and generic drugs markets are expanding. In addition, the successive failure of patents for branded drugs and the increased use of generic drugs will also boost the pharmaceutical production in Brazil, Egypt, Hungary, Indonesia, Poland, and South Korea and the demand for related pharmaceutical packaging.
Precharged more and more popular
The shift in the focus of drug research and drug delivery methods will inevitably provide exciting prospects for manufacturers of prefilled inhalers and prefilled syringes. In the global primary packaging market, this is two areas of rapid growth. It is estimated that by 2013, the market value of these two areas will reach 2.28 billion U.S. dollars and 3.37 billion U.S. dollars, respectively. Changes in the needs of patients and regulatory agencies, the introduction of new bioengineered drugs, and the need to remain competitive will prompt these primary packaging markets to continue to expand and contribute to sustained growth. However, plastic bottles will continue to occupy the largest market share because of its low cost, versatility and availability, and quality and design are continuously improving. Sales of blister packaging, small bags, and filling tapes are also expected to increase.
At the same time, the global market for medicinal plugs and accessories will increase at an annual rate of 6.5 percent, reaching US$24.1 billion by 2013.
According to Freedonia Group's research, the growth of this market is mainly driven by the following factors: The use of prescription-prevention containers for child-resistance and compatibility with older people is increasing; the use of prescription drug containers to improve drug compliance; the visual effect of labels has been enhanced. Anti-interference and anti-counterfeiting accessories.
Future market opportunities
Due to constant pressure to reduce costs and improve efficiency, pharmaceutical packaging companies must change their overall business strategy if they want to obtain a reasonable profit. Martineau pointed out that manufacturers should raise the level of packaging equipment to accommodate high efficiency and small batch production. He also suggested adopting a contract packaging system that allows companies to expand their generic line of packaging products. Where feasible, pharmaceutical packers must also remove any unnecessary secondary packaging. In addition, Martineau believes that pharmaceutical packers should increase their suitability for providing services to pharmaceutical companies, especially packaging design, selection and installation of packaging equipment, and contract packaging production.
According to data provided by Freedonia Grou, there are approximately 2,000 companies worldwide producing pharmaceutical packaging products. In terms of 2008 revenues, 8 multinational companies supplied almost a quarter of the pharmaceutical packaging products worldwide, namely Rexam, MeadWestvaco, Gerresheimer, Becton Dickinson, Amcor, Catalent, West and Alcan.
For companies wishing to maintain or increase their market share, they must adapt to the future development of the pharmaceutical packaging market. In the next few years, the biggest growth opportunities in the pharmaceutical packaging market will be in the production sector: increased safety labels and packaging accessories; unit dose blister packaging boxes for clinical trials and post-approval applications; improved safety and carrying recyclable needles Pre-filled syringes; pre-filled inhalers for single-dose medications; drug-use caps for liquid and pasty medicines.
â–²According to a survey conducted by Pharmaceutical Technology Europe (PTE), almost 50% of respondents believe that cost is the biggest constraint to innovation activities in the pharmaceutical packaging industry; almost two-thirds of respondents believe that the regulatory It is a major obstacle to innovation.
â–² In another survey conducted by PTE, 85% of respondents believe that the pharmaceutical industry needs to adopt more environmentally friendly packaging methods.
Professional customized oven control panel, products and services are of good quality, cost-effective, and save you purchase costs. We are a professional manufacturer of dotted glass to meet the glass customization needs of thousands of dotted products. We strictly follow various systems for production, and win customers' affirmation through highly competitive prices, excellent quality, timely delivery time, and perfect after-sales service system. We specialize in the production of glass, as well as Tempered Glass for microwave ovens, ovens and other household appliances. Through continuous development, we have a deep processing foundation and strong technical capabilities. The company is equipped with advanced glass production lines, superb technicians, and senior art cutting experts to achieve a perfect pursuit for your products. we areChina Glass Door For Microwave Oven ,Tempered Glass Sheet supplier & manufacturer, offer low price, high quality Oven Door Tempered Glass ,Tempered Oven Glass, etc.
Glass Door For Microwave Oven ,Tempered Glass Sheet ,Oven Door Tempered Glass ,Tempered Oven Glass
WCH Temper Glass Co., Ltd , https://www.temperglasswch.com